Tilt table test could be key to stopping fainting spells
NCT ID NCT07459478
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a tilt table test, which provokes fainting in a controlled setting, can help people with vasovagal syncope (common fainting) reduce future episodes. About 238 adults will be randomly assigned to receive biofeedback training either with or without the tilt table test. The goal is to see if the test leads to fewer fainting episodes and better quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tilt table testing
- What this could lead to
- If successful, this could show that tilt table testing helps people with fainting spells avoid future episodes when combined with biofeedback.
- What could go wrong
- This is a relatively small, early-stage trial. The tilt table test may not reduce fainting more than biofeedback alone, and results may not apply to all types of fainting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOVAGAL SYNCOPE (VVS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.